>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • REAL +29%, VIAV +26.6%, LZ +24.7%, LASR +23.4%, PSIX +22.9%, SOUN +22.2%, OUST +20.6%, TRUP +20.1%, EXPE +16.5%, FROG +15.9%, ABCL +15.1%, ARLO +14.5%, CART +14%, NTRA +13.4%, JAMF +13.2%, EMBC +12.9%, ANIP +12.7%, NGVC +12.3%, GCT +12.2%, WLDN +12%, AORT +10.4%, ABL +10%, FIGS +9.6%, XYZ +8.7%, DOCS +8.5% (also acquires Pathway), PGNY +8.3%, MNST +8.1%, ARRY +7.9%, MP +7.7%, TXG +7.4% (also to acquire Scale Biosciences), ORGO +7.1%, DVAX +7%, TEM +7%, SYNA +6.3% (also authorizes new $150 mln share repurchase program), TTWO +6.3%, KRMN +5.8%, TRIP +5.7%, GILD +5.6%, AMPX +5.6%, AHR +5.5%, PLUS +5.3% (also initates dividend), ASTH +5.1%, WEST +5.1%, GSAT +4.7%, ZYME +4.4%, CMPO +4.4%, CLMT +4.3%, EGY +4.2%, IAS +4.1%, CGC +3.8%, WULF +3.6%, AKAM +3.3%, DH +3.3%, ALRM +3.2%, ATMU +3.1%, G +3%, POST +3% (also COO to retire), CRSR +2.8%, GMED +2.5%, TEAM +2.3%, ATGE +2.3%, CRNX +2.2%, AKRO +2%, INDI +1.8%, SOLV +1.8%, CYTK +1.8%, RKLB +1.7% (also successful completion of Systems Integration Review), WPM +1.7%, AMCX +1.5%, ONTO +1.4%, ACA +1.3%, DNN +1.3%, GEN +1.2%, MSI +1.1%, ED +1%, OTEX +1% (also increases dividend, announces $300 mln repurchase), AQN +1%
Other news:
  • MRCC +9% (MRCC and HRZN to merge)
  • OBIO +3.5% (announces the roll out of a protocol update, approved by the U.S. FDA, that significantly expands patient eligibility criteria for enrollment of the BACKBEAT study evaluating AVIM therapy in pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications)
  • NXDR +2.7% (restructuring plan, CFO to retire)
  • MDU +2.3% (files mixed securities shelf offering; also enters into $400 mln distribution agreement)
  • HGTY +2.2% (prices secondary offering of 9.7 mln shares of common stock at $9.34 per share)
  • LUMN +1.9% (CEO discloses purchase of 135,870 shares)
  • ATYR +1.7% (files for $300 mln mixed securities shelf offering)
  • OI +1.5% (insiders buying additional stock)
  • AEE +1.1% (amends equity distribution sales agreement increasing aggregate gross sales price authorized by $1.25 bln)
  • CXW +1% (judge orders construction of detention center be halted, according to AP)
  • LITE +1% (announces capacity expansion of US facility)
  • ARMK +1% (CEO disclosed the purchase of 6,387 shares)
  • TFX +1% (discloses flurry of insider buys)
  • BWIN +1% (CFO / Member of 10% owner group bought 10,000 shares)
  • JCI +1% (entered into accelerated share repurchase transactions to repurchase $5.0 bln ordinary shares)